Open AccessIs cytisine contraindicated in smoking patients with coronary artery disease after percutaneous coronary intervention?
Author(s) -
Bogumił Ramotowski,
Andrzej Budaj
Publication year - 2021
Publication title -
kardiologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 34
eISSN - 1897-4279
pISSN - 0022-9032
DOI - 10.33963/kp.a2021.0025
Subject(s) - medicine , cytisine , interquartile range , percutaneous coronary intervention , coronary artery disease , adverse effect , conventional pci , incidence (geometry) , smoking cessation , cardiology , myocardial infarction , physics , receptor , nicotinic agonist , pathology , optics
Cytisine is contraindicated, and its effects have not been evaluated in patients with coronary artery disease (CAD).